Direct oral anticoagulants and venous thromboembolism Source: Eur Respir Rev 2016; 25: 295-302 Year: 2016
Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020
Enoxaparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002
Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin. Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019
Low-molecular-weight heparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 381s Year: 2001
Efficiency of r-TPA therapy in major venous thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016
Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021
Risk of venous thromboembolism in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004
Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018
Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007
Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
Incidental venous thromboembolism, detected by chance, but still venous thromboembolism Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020 Year: 2020
Venous thrombo-embolism prophylaxis Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009
Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016
Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015
Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients Source: Eur Respir J 2004; 24: Suppl. 48, 273s Year: 2004
Genetic and acquired risk factors of venous thromboembolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=1 Year: 2004
Venous thromboembolic disease and bronchial cancer Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012
A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE) Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019